About gadopente tate dimeglumin
Gadolinium-based MRI contrast agent
Used for
- Enhances MRI images of the brain, spine, and other body areas.
- Helps identify tumors, inflammation, abnormal blood vessels, and other tissue changes.
Usual adult dose
Usually 0.1 mmol/kg by intravenous injection; some examinations use different doses.
Usual dose in children
Usually 0.1 mmol/kg by intravenous injection; dosing depends on the examination and age.
Common side effects
- Headache, nausea, or dizziness
- Injection-site pain or warmth
- Allergic reactions, rarely severe
- Nephrogenic systemic fibrosis in severe kidney disease, very rarely
Important warnings
- Serious kidney disease increases risk of nephrogenic systemic fibrosis.
- Rare severe allergic reactions can occur.
- Use the lowest effective dose; avoid repeat doses when possible.
- Tell imaging staff about kidney problems or prior contrast reactions.
Pregnancy
Use only when essential; human pregnancy safety information is limited.
Breastfeeding
Breastfeeding usually need not be interrupted after a dose.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.